Hungarian Biotech Database

SEOUL, South Korea, June 16, 2020 /PRNewswire/ -- Medit announces the nomination of its new Chief Executive Officer, GB (Gyu Bum) Ko, amidst the company's 20(th) year as a global provider of 3D scanning solutions. Ko joins Medit to accelerate its growth strategy as a leader in the dental... Read more ››

By: PR Newswire Association LLC. - 16 Jun 2020

Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases

By: GlobenewsWire - 11 Jun 2020

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ››

By: PR Newswire Association LLC. - 09 Jun 2020

Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma

By: GlobenewsWire - 02 Jun 2020

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline

By: GlobenewsWire - 02 Jun 2020

Sanofi announces closing of Regeneron stock sale

By: GlobenewsWire - 29 May 2020

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

By: GlobenewsWire - 29 May 2020

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

By: GlobenewsWire - 26 May 2020

1 2 3 4 »

Looking for companies outside of Hungary?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

July 2020
- Digital Novel Coronavirus Investment Forum Empowering Early
- Florida: Evolution Summit
- Taipei: BIO Asia-Taiwan

See Events »

Add an Event »

Latest company news

Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients
02 Jul 2020 (GlobenewsWire)

Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients
23 Jun 2020 (GlobenewsWire)

Sanofi: Information concerning the total number of voting rights and shares - May 2020
19 Jun 2020 (GlobenewsWire)

News in the Life Sciences Industry

Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients

Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients

Sanofi: Information concerning the total number of voting rights and shares - May 2020

Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B, with or without inhibitors

Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease

Sanofi invests to make France its world class center of excellence in vaccine research and production

Medit Celebrates 20th Anniversary and Appoints GB (Gyu Bum) Ko as New CEO to Accelerate Growth Strategy

Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease

Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan

European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma

Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline

Sanofi announces closing of Regeneron stock sale

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

Sanofi names new leaders to Executive Committee

Sanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent Director

Sanofi announces pricing of Regeneron stock offering

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

Looking for companies outside of Hungary?

Partners

Upcoming Life Sciences Events

Latest company news